245 related articles for article (PubMed ID: 31902250)
21. Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital.
Ito Y; Miyauchi A; Fujishima M; Yamamoto M; Sasaki T
Endocr J; 2024 Jan; 71(1):7-21. PubMed ID: 37793883
[TBL] [Abstract][Full Text] [Related]
22. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
[TBL] [Abstract][Full Text] [Related]
24. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
Cheema Y; Olson S; Elson D; Chen H
J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
[TBL] [Abstract][Full Text] [Related]
25. Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.
Molinaro E; Campopiano MC; Pieruzzi L; Matrone A; Agate L; Bottici V; Viola D; Cappagli V; Valerio L; Giani C; Puleo L; Lorusso L; Piaggi P; Torregrossa L; Basolo F; Vitti P; Tuttle RM; Elisei R
J Clin Endocrinol Metab; 2020 Mar; 105(3):e172-80. PubMed ID: 31652318
[TBL] [Abstract][Full Text] [Related]
26. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
27. [Current treatment strategies for papillary thyroid microcarcinoma].
Weber T
Chirurg; 2020 Dec; 91(12):994-998. PubMed ID: 32776249
[TBL] [Abstract][Full Text] [Related]
28. Managing thyroid microcarcinomas.
Mazzaferri EL
Yonsei Med J; 2012 Jan; 53(1):1-14. PubMed ID: 22187228
[TBL] [Abstract][Full Text] [Related]
29. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
30. Active surveillance of low-risk papillary thyroid microcarcinomas.
Ito Y; Miyauchi A
Gland Surg; 2020 Oct; 9(5):1663-1673. PubMed ID: 33224844
[TBL] [Abstract][Full Text] [Related]
31. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
[TBL] [Abstract][Full Text] [Related]
32. Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?
Stefanova DI; Bose A; Ullmann TM; Limberg JN; Finnerty BM; Zarnegar R; Fahey TJ; Beninato T
World J Surg; 2020 Feb; 44(2):452-460. PubMed ID: 31605172
[TBL] [Abstract][Full Text] [Related]
33. Surgical considerations for papillary thyroid microcarcinomas.
Boucai L; Bernet V; Shaha A; Shindo ML; Stack BC; Tuttle RM
J Surg Oncol; 2017 Sep; 116(3):269-274. PubMed ID: 28513849
[TBL] [Abstract][Full Text] [Related]
34. Thyroid surgery for differentiated thyroid cancer - recent advances and future directions.
Wang TS; Sosa JA
Nat Rev Endocrinol; 2018 Nov; 14(11):670-683. PubMed ID: 30131586
[TBL] [Abstract][Full Text] [Related]
35. Risk factors associated with intrathyroid extension of thyroid microcarcinomas.
Slijepcevic N; Zivaljevic V; Diklic A; Jovanovic M; Oluic B; Paunovic I
Langenbecks Arch Surg; 2018 Aug; 403(5):615-622. PubMed ID: 29770856
[TBL] [Abstract][Full Text] [Related]
36. The non-interventional approach to papillary thyroid microcarcinomas. An "active surveillance" dilemma.
Paparodis RD; Bantouna D; Imam S; Jaume JC
Surg Oncol; 2019 Jun; 29():113-117. PubMed ID: 31196473
[TBL] [Abstract][Full Text] [Related]
37. Differences in the characteristics of papillary thyroid microcarcinoma ≤5 mm and >5 mm in diameter.
Kim E; Choi JY; Koo do H; Lee KE; Youn YK
Head Neck; 2015 May; 37(5):694-7. PubMed ID: 24596325
[TBL] [Abstract][Full Text] [Related]
38. Conservative thyroidectomy for papillary thyroid microcarcinoma.
Nahm HJ; Choi SJ; Lim YC
Am J Otolaryngol; 2019; 40(3):427-430. PubMed ID: 30928297
[TBL] [Abstract][Full Text] [Related]
39. Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy.
Lee YS; Lim H; Chang HS; Park CS
J Korean Med Sci; 2014 May; 29(5):676-9. PubMed ID: 24851024
[TBL] [Abstract][Full Text] [Related]
40. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
